Randomized Phase II Biomarker Pilot Trial of Fluvastatin Use in Women With Ductal Carcinoma in Situ (DCIS) or Stage I Breast Cancer.

Trial Profile

Randomized Phase II Biomarker Pilot Trial of Fluvastatin Use in Women With Ductal Carcinoma in Situ (DCIS) or Stage I Breast Cancer.

Completed
Phase of Trial: Phase II

Latest Information Update: 12 Dec 2012

At a glance

  • Drugs Fluvastatin (Primary)
  • Indications Breast cancer; Early breast cancer
  • Focus Biomarker; Pharmacodynamics
  • Most Recent Events

    • 07 Jun 2017 Biomarkers information updated
    • 08 Feb 2010 Status changed from recruiting to completed.
    • 01 Jan 2010 Primary endpoint results published in the Breast Cancer Research and Treatment 119: 137-144, No. 1, 1 Jan 2010.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top